Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative?
- 31 May 1999
- journal article
- editorial
- Published by Elsevier BV in Gastroenterology
- Vol. 116 (5), 1246-1249
- https://doi.org/10.1016/s0016-5085(99)70029-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Lactobacillus species prevents colitis in interleukin 10 gene–deficient miceGastroenterology, 1999
- Continuous feeding of Lactobacillus plantarum attenuates established colitis in interleukin-10 deficient miceGastroenterology, 1998
- Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileumGastroenterology, 1998
- Enteric microflora in IBD: Pathogens or commensals?Inflammatory Bowel Diseases, 1997
- Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria.Gut, 1996
- Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)Clinical and Experimental Immunology, 1995
- Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of PrebioticsJournal of Nutrition, 1995
- Insights into the pathogenesis of inflammatory bowel diseases provided by new rodent models of spontaneous colitisInflammatory Bowel Diseases, 1995
- Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileumThe Lancet, 1991
- Double blind, placebo controlled trial of metronidazole in Crohn's disease.Gut, 1991